申请人:Boehringer Mannheim GmbH
公开号:US04229464A1
公开(公告)日:1980-10-21
New aminopropanol compounds of the formula ##STR1## wherein R is lower alkyl, cycloalkyl or alkylthioalkyl, R.sub.1 is hydrogen or lower alkyl, hydroxyalkyl, pivaloyloxyalkyl, alkoxyalkyl, alkoxycarbonyl, carboxyl or --CONR.sub.3 R.sub.4, in which R.sub.3 and R.sub.4 which can be the same or different, represent hydrogen or lower alkyl, and R.sub.2 is lower alkyl, hydroxyalkyl, alkoxyalkyl or pivaloyloxyalkyl or, when R is alkylthioalkyl or R.sub.1 is pivaloyloxyalkyl, R.sub.2 can also be hydrogen and the pharmacologically acceptable salts thereof; are outstandingly effective in the treatment or prophylaxis of cardiac and circulatory diseases.
新的氨基丙醇化合物的化学式为##STR1## 其中R是较低的烷基,环烷基或烷基硫基烷基,R.sub.1是氢或较低的烷基,羟基烷基,皮瓦酰氧基烷基,烷氧基烷基,烷氧羰基,羧基或--CONR.sub.3 R.sub.4,在其中R.sub.3和R.sub.4可以相同或不同,表示氢或较低的烷基,R.sub.2是较低的烷基,羟基烷基,烷氧基烷基或皮瓦酰氧基烷基,或当R为烷基硫基烷基或R.sub.1为皮瓦酰氧基烷基时,R.sub.2也可以是氢,并且其药理学可接受的盐,在心脏和循环疾病的治疗或预防方面具有卓越的疗效。